Vaccine Shedding

Vaccine shedding refers to the process by which biological material originating from a vaccine — or produced as a result of vaccination — is released from the body of a vaccinated individual and potentially transmitted to others through close contact, bodily fluids, exhaled breath, or other routes. While classical shedding has long been recognised in the context of live attenuated viral vaccines, the widespread rollout of mRNA-based COVID Vaccines and associated Lipid Nanoparticles has prompted researchers, clinicians, and commentators to expand the concept considerably — raising questions about spike protein transmission, exosome transfer, and even the possible transmission of Self-Assembling Nanostructures and Graphene Oxide-based components. These claims intersect directly with concerns around Bodily Autonomy and Informed Consent, particularly for those who chose not to receive a COVID-19 injection.

Classical Shedding: The Established Baseline

Shedding in the conventional sense is well-documented and is not disputed by mainstream science. Live attenuated vaccines — those using a weakened form of a pathogen — can result in detectable quantities of the vaccine strain being excreted by the recipient. This has been documented for:

Oral polio vaccine (OPV) — the Sabin strain can be shed in faeces and has, in rare cases, caused vaccine-derived polio in unvaccinated contacts
Measles, Mumps and Rubella (MMR) vaccine — low-level shedding of attenuated measles virus has been detected in vaccinated individuals
Chickenpox (varicella) vaccine — rare transmission of the attenuated VZV strain to immunocompromised contacts has been documented
Influenza nasal spray vaccine (FluMist/Fluenz) — the live attenuated influenza vaccine is explicitly labelled with shed-risk warnings for immunocompromised households

Regulatory bodies including the FDA and the European Medicines Agency (EMA) have historically required evaluation of shedding potential in live vaccine candidates. The FDA's 2015 guidance document Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy and Oncolytic Products explicitly acknowledges shedding as a safety consideration for novel biological products — a fact cited by critics who argue the same scrutiny should apply to lipid nanoparticle-based products.

Spike Protein Shedding

The COVID-19 mRNA vaccines instruct the cells of the recipient to produce the SARS-CoV-2 spike protein. Unlike the pathogen itself, the spike protein is a discrete biological entity that can circulate systemically and, some researchers argue, be released into external secretions.

Published and Preprint Evidence

A 2022 study published in the Journal of Immunology (Ogata et al.) detected free circulating spike protein in the plasma of vaccinated individuals for up to two weeks post-injection — distinct from spike protein bound to antibodies.
Research from the University of California San Francisco (Brogna et al., 2023 preprint) claimed to detect spike protein in the exhaled breath condensate of vaccinated individuals, suggesting an aerosol transmission pathway exists in principle.
A 2023 preprint (Bansal et al.) reported the presence of spike protein in breast milk of vaccinated nursing mothers, raising transmission concerns for infants.
Studies examining bodily secretions post-vaccination have additionally noted spike protein presence in sweat and saliva, though the significance and transmissibility remain contested.

Some researchers, including Robert Duncan and commentators in the Targeted Individual research space, have drawn parallels between spike protein dispersion and earlier work on pathogen aerosolisation, noting that engineered proteins may behave differently from naturally shed viral particles.

Cardiovascular and Neurological Relevance

The spike protein is known to bind the ACE2 receptor, present throughout the human body including the cardiovascular system, brain, and reproductive organs. If spike protein produced by a vaccinated individual can be inhaled or absorbed by an unvaccinated person, this receptor-binding potential applies to the recipient as well — an argument advanced by clinicians such as Dr. Peter McCullough in published correspondence and public presentations.

Exosome Transmission

Exosomes are small extracellular vesicles — typically 30–150 nanometres in diameter — naturally secreted by virtually all human cell types. They carry proteins, lipids, and RNA between cells and are now understood to play significant roles in immune signalling and intercellular communication.

Lipid Nanoparticles and Exosome Mimicry

Lipid Nanoparticles (LNPs) — the delivery vehicle used in Pfizer-BioNTech and Moderna mRNA vaccines — are structurally analogous to exosomes. Key overlaps include:

Similar size range (50–200 nm)
Phospholipid bilayer construction
Ability to fuse with or be taken up by cell membranes
Capacity to carry nucleic acid cargo

According to researchers including Dr. Stephanie Seneff and Professor Giannino Soldati, the LNPs and/or vaccine-induced exosomes released by transfected cells may carry mRNA fragments, spike protein subunits, or other biological payload. These vesicles could in principle be shed in bodily fluids and inhaled or absorbed by others.

A 2022 paper in the Journal of Extracellular Vesicles documented that COVID-19 spike protein could be packaged into exosomes and secreted by cells, opening a biological route distinct from direct aerosol transmission of free protein.

Nanotechnology Shedding Hypothesis

Perhaps the most contested expansion of the shedding concept involves the possibility that nanoscale technological or quasi-technological structures present in certain vaccine batches may also be transmitted from vaccinated to unvaccinated individuals.

Graphene Oxide and Self-Assembling Structures

Dr. Ana Maria Mihalcea, an internal medicine physician and researcher, has documented anomalous structures in the blood of both vaccinated and — critically — unvaccinated individuals who report close contact with vaccinated persons. Her published microscopy work shows filamentous, lattice-like, and crystalline structures that she interprets as consistent with Graphene Oxide or Self-Assembling Nanostructures.

Mihalcea's position, shared by researchers at La Quinta Columna including Ricardo Delgado, is that:

Graphene Oxide and reduced graphene oxide (rGO) may be present in COVID vaccine formulations
These materials have known capacities for self-assembly into nano-scale architectures under certain electromagnetic and biochemical conditions
Graphene-based structures may be shed via exhaled aerosols, sweat, or other secretions
Unvaccinated individuals with anomalous blood findings who have never been injected may be experiencing secondary exposure

This hypothesis interfaces with the broader Intra-Body Nano Network framework, in which nanoscale components introduced into the body are theorised to form functional networks capable of biosensing, communication, or biometric monitoring.

Morgellons and Environmental Nanoparticle Exposure

Some researchers draw a line of connection between the nanotechnology shedding hypothesis and Morgellons — a condition involving anomalous fibrous structures emerging from the skin. Critics note that both vaccinated and unvaccinated individuals have reported Morgellons-like findings, which some interpret as consistent with environmental or interpersonal nanoparticle transmission rather than direct injection.

Independent Researcher Findings

Mik Andersen, writing under the pseudonym Corona2Inspect, has published extensive analyses claiming to demonstrate graphene-related nanostructures in vaccine vials and blood samples. Andersen's work, while not peer-reviewed in mainstream journals, has been cited by Mihalcea and others as supporting the shedding-of-nanotechnology thesis.

Dr. Pablo Campra, a professor of chemical sciences at the University of Almeria, published a technical report in 2021 claiming to identify graphene oxide in a Pfizer vaccine sample using micro-Raman spectroscopy. Although the mainstream scientific community disputes this finding, it forms a foundational reference point for the nanotechnology shedding hypothesis.

Clinical Reports from Unvaccinated Individuals

A significant body of anecdotal and semi-clinical evidence has accumulated since 2021 from unvaccinated individuals reporting symptoms following close contact with recently vaccinated persons. Commonly reported presentations include:

Unusual or irregular menstrual cycles in women — including delayed, early, heavier, or absent periods
Unexplained bruising or petechiae
Fatigue and brain fog
Headaches
Cardiovascular irregularities including palpitations
Skin rashes or unusual dermatological findings

These reports have been compiled by organisations including America's Frontline Doctors, and documented in submissions to the Children's Health Defense and related bodies. Mainstream health authorities have attributed these reports to psychosomatic effects, stress, or coincidence. Critics of that dismissal note that the mechanistic pathways described above — spike protein aerosolisation, exosome transmission — offer biologically plausible explanations.

Blood Findings in Unvaccinated Individuals

Dr. Ana Maria Mihalcea and colleagues conducting Live Blood Analysis on unvaccinated control subjects have reported:

Filamentous structures not typical of standard haematological findings
Reduced erythrocyte (red blood cell) integrity, including rouleaux formation
Crystalline or geometrically regular micro-objects in plasma
Structures consistent in morphology with those observed in vaccinated subjects, though typically less dense

Mihalcea's interpretation is that these findings represent either secondary nanoparticle exposure through shedding, or environmental contamination via Geoengineering-related aerosol programs. She has called for independent replication studies and international investigations. Her blood analysis documentation is publicly available on her Substack platform Ana Maria Mihalcea, MD, PhD.

LNP Biodistribution and the Shedding Vector

Internal FDA documents released in response to Freedom of Information requests (notably from the Japanese Pharmaceuticals and Medical Devices Agency) revealed that Lipid Nanoparticles carrying the mRNA payload did not remain localised at the injection site as originally claimed. Rather, LNPs were found to distribute throughout the body, including to:

The liver (highest concentration outside the injection site)
Adrenal glands
Ovaries
Spleen and bone marrow

This widespread biodistribution is significant for the shedding debate because:

LNPs circulating in blood and lymph may be excreted in trace quantities in sweat, mucus, and breath
Cells in multiple organ systems transfected by circulating LNPs become spike protein producers — expanding the possible secretory surface area

The connection between LNP biodistribution and shedding potential is discussed in the broader context of Intra-Body Nano Network research and the Nano-tech field.

Regulatory Acknowledgement

The FDA's guidance document on shedding studies (2015) explicitly defines shedding as "the release of VBGT [virus- or bacteria-based gene therapy] or oncolytic products from the patient through one or all of the following ways: excreta (faeces); secreta (urine, saliva, nasopharyngeal fluids etc.); or through the skin (pustules, sores, wounds)."

Critics including attorney Dr. Reiner Füllmich and members of the Corona Investigative Committee have argued that mRNA COVID vaccines — classified as gene therapy products in some jurisdictions — should have been subject to this existing regulatory framework, including mandatory shedding studies prior to deployment. The absence of such studies is cited as a regulatory failure contributing to post-market harms and Bodily Autonomy violations for unvaccinated third parties.

Implications for Bodily Autonomy and Informed Consent

The shedding question carries profound implications beyond virology and biochemistry.

Bodily Autonomy — the right of individuals to decide what enters their own body — is enshrined in medical ethics and international law, including the Nuremberg Code and the Declaration of Helsinki. If vaccine-derived biological or nanotechnological material can be transmitted to third parties without their consent, this creates a second-order autonomy violation: the unvaccinated individual, having declined the injection, may nonetheless receive its biological outputs via proximity.

Informed Consent requires that individuals be made aware of all foreseeable risks. If shedding poses any risk to unvaccinated contacts — particularly pregnant women, immunocompromised individuals, or infants — this information would need to be disclosed at the point of vaccination under any meaningful informed consent framework. Critics note that no such disclosure was made during the COVID-19 vaccine rollout.

These arguments have been raised before courts and regulatory bodies in multiple jurisdictions and are documented in Bodily Autonomy Legislation proceedings and public interest submissions.

Anonymous

Search

Vaccine Shedding

Namespaces

More

Page actions

Contents

Classical Shedding: The Established Baseline